(Total Views: 711)
Posted On: 02/18/2022 9:03:57 AM
Post# of 154238
I remain optimistic that the pending audit of Amerex will be very revealing:
Possible revisit CD 10 and 12, NASH, nTNBC, HIV?
Might we resubmit request for approval based on updated data?
I any case, probable suit/settlement for damages could provide a windfall, based on strong evidence coming from our buddies at FDA.
We had to go after the data. It’s time for Leronlimab!
Possible revisit CD 10 and 12, NASH, nTNBC, HIV?
Might we resubmit request for approval based on updated data?
I any case, probable suit/settlement for damages could provide a windfall, based on strong evidence coming from our buddies at FDA.
We had to go after the data. It’s time for Leronlimab!
(7)
(0)
